YSPH Partners With University of Puerto Rico to Address HIV

Researchers at the Yale School of Public Health are teaming up with colleagues at the University of Puerto Rico to improve access to testing, treatment and care for people living with HIV in the capital city, San Juan.

With support from the National Institutes of Health, the Yale Center for Interdisciplinary Research on AIDS (CIRA) and the University of Puerto Rico Medical Sciences Campus (UPR-MSC) are launching two projects designed to address Puerto Rico’s urgent HIV problem as part of the federal government’s Ending the HIV Epidemic initiative. The new grants are supported by an NIH program that aims to facilitate HIV implementation research in high-burden areas in the United States.

In the first project, a collaborative research team will work with men and women with HIV in San Juan to assess the feasibility of providing rapid oral fluid HIV self-test kits to partners of people living with HIV and to identify ways of overcoming existing barriers to treatment. Through focus groups and meetings, the team will also assess the feasibility of initiating Pre-Exposure Prophylaxis for HIV-negative partners.

“We are very excited about the ways in which these supplements will allow us to build a collaborative relationship with our partners at the University of Puerto Rico, while addressing some of the “Pillars” (Diagnose, Treat, Protect, and Respond) of the Ending the Epidemic initiative,” said Paul Cleary, the Anna M.R. Lauder Professor of Public Health, director of CIRA, and Yale’s principal investigator on the self-testing study.

The project is supported by a $172,000 grant from the National Institutes of Health (NIH).

Scroll to Top

During the Canada Post strike announced September 25, 2025, the following measures will be undertaken to minimize service disruption to BC-CfE clients and providers.

  • The BC-CfE Laboratory has transitioned to private courier for delivery of outgoing reports and documents. Results required urgently can be faxed upon request. (Lab Contact Information: Phone 604-806-8775; FAX 604-806-9463)
  • The BC-CfE Drug Treatment Program (DTP) will fax outgoing forms and documents to the provider’s office. (DTP Contact Information: Phone 604-806-8515; FAX 604-806-9044)
  • St. Paul’s Hospital Ambulatory Pharmacy has transitioned to private courier for delivery of medications. We recommend requesting medication at least 2 weeks in advance in case of delivery delays, particularly to rural/remote parts of BC. (Contact Information: Phone 1-800-547-3622; FAX 604-806-8675)

During the Canada Post strike, we recommend that documents be faxed or couriered to our sites, versus utilization of regular mail service

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below